Cover Image
市場調查報告書

缺鐵性貧血:全球臨床實驗檢討

Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 322170
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
缺鐵性貧血:全球臨床實驗檢討 Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月31日 內容資訊: 英文 105 Pages
簡介

本報告提供缺鐵性貧血的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 缺鐵性貧血
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:血液疾病臨床實驗上缺鐵性貧血所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:血液疾病臨床實驗上缺鐵性貧血所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

缺鐵性貧血治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Galenica Ltd.
    • 第一三共
    • Pharmacosmos A/S
    • AMAG Pharmaceuticals, Inc.
    • Rockwell Medical, Inc.
    • Shield Therapeutics
    • Actavis plc
    • Laboratoires Pierre Fabre SA
    • Keryx Biopharmaceuticals, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Swiss Federal Institute of Technology
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • University of Zurich
    • Soroka University Medical Center
    • Wageningen University
    • Stanford University
    • University of Oxford
    • The Hospital for Sick Children
    • Imperial College London
    • HaEmek Medical Center

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2516CTIDB

GlobalData's clinical trial report, "Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014" provides data on the Iron Deficiency Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Iron Deficiency Anemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Iron Deficiency Anemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Iron Deficiency Anemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Iron Deficiency Anemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Iron Deficiency Anemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Iron Deficiency Anemia
    • Dec 08, 2014: American Regent Announces Clinical Data Presentations at ASH 2014
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Galenica Ltd.
      • Clinical Trial Overview of Galenica Ltd.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Pharmacosmos A/S
      • Clinical Trial Overview of Pharmacosmos A/S
      • AMAG Pharmaceuticals, Inc.
      • Clinical Trial Overview of AMAG Pharmaceuticals, Inc.
      • Rockwell Medical, Inc.
      • Clinical Trial Overview of Rockwell Medical, Inc.
      • Shield Therapeutics
      • Clinical Trial Overview of Shield Therapeutics
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Laboratoires Pierre Fabre SA
      • Clinical Trial Overview of Laboratoires Pierre Fabre SA
      • Keryx Biopharmaceuticals, Inc.
      • Clinical Trial Overview of Keryx Biopharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Swiss Federal Institute of Technology
      • Clinical Trial Overview of Swiss Federal Institute of Technology
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • University of Zurich
      • Clinical Trial Overview of University of Zurich
      • Soroka University Medical Center
      • Clinical Trial Overview of Soroka University Medical Center
      • Wageningen University
      • Clinical Trial Overview of Wageningen University
      • Stanford University
      • Clinical Trial Overview of Stanford University
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • The Hospital for Sick Children
      • Clinical Trial Overview of The Hospital for Sick Children
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • HaEmek Medical Center
      • Clinical Trial Overview of HaEmek Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
  • Iron Deficiency Anemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Iron Deficiency Anemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
  • Iron Deficiency Anemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Iron Deficiency Anemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Iron Deficiency Anemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Galenica Ltd., 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacosmos A/S, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AMAG Pharmaceuticals, Inc., 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rockwell Medical, Inc., 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shield Therapeutics, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Keryx Biopharmaceuticals, Inc., 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Federal Institute of Technology, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Soroka University Medical Center, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Wageningen University, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014*

List of Figures

  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
  • Iron Deficiency Anemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Iron Deficiency Anemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
  • Iron Deficiency Anemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Iron Deficiency Anemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Iron Deficiency Anemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top